Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Malbork – page 3

34 clinical trials in Malbork, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Malbork at a glance
34
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

34 trials in Malbork

Open in trial search

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Psoriasis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tildrakizumab
  • Sponsor:Sun Pharmaceutical Industries Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Naronapride Dihydrochloride Trihydrate
  • Sponsor:Dr. Falk Pharma GmbH

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Daxdilimab
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Hidradenitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac Diethylamine
  • Sponsor:Haleon CH SARL

Hand dermatitis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Dermatitis atopic

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
  • Sponsor:LEO PHARMA A/S
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Dry Extract From Chaste Tree Fruits (7-11:1), Extraction Solvent: Ethanol 70% (V/V)
  • Sponsor:Bionorica SE

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Malbork

What the registry says about research in the country

01 Dermatological Conditions

Studies focusing on various skin conditions including genital psoriasis, atopic dermatitis, and chronic hand eczema. Research evaluates new topical treatments and systemic therapies for improved patient outcomes.

  • Psoriasis Management
  • Eczema Treatment
  • Dermatitis Control

Novel therapeutic approaches aim to address both symptoms and underlying causes of skin disorders.

02 Autoimmune Disorders

Clinical investigations targeting conditions like Sjögren's Syndrome and lupus erythematosus. Research focuses on evaluating innovative treatments for managing systemic manifestations and improving quality of life.

  • Systemic Disease Management
  • Immune System Modulation
  • Symptom Control

Studies aim to develop targeted therapies for complex autoimmune conditions.

03 Metabolic and Gastrointestinal Disorders

Research examining treatments for hypertriglyceridemia and gastroparesis. Studies evaluate medication efficacy for managing metabolic disorders and digestive system conditions.

  • Lipid Management
  • Digestive Health
  • Metabolic Control

Innovative approaches focus on improving patient outcomes in metabolic and digestive disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.